First Trust Advisors Boosts ResMed Stake by 285%

The investment firm now owns over 445,000 shares of the medical equipment provider.

Published on Mar. 9, 2026

Got story updates? Submit your updates here. ›

First Trust Advisors LP increased its stake in ResMed Inc. (NYSE:RMD) by 285.1% in the 3rd quarter, according to a recent SEC filing. The fund now owns 445,198 shares of the medical equipment provider's stock, worth approximately $121.9 million.

Why it matters

ResMed is a leading manufacturer of sleep apnea and respiratory care devices. The significant increase in First Trust Advisors' position suggests the firm sees strong growth potential in the company, which could signal positive market sentiment around ResMed's business performance and future outlook.

The details

First Trust Advisors purchased an additional 329,588 shares of ResMed during the quarter, bringing its total position to 445,198 shares. This represents approximately 0.31% of ResMed's outstanding stock. The investment firm cited the medical equipment provider's strong market position and growth prospects as reasons for increasing its stake.

  • First Trust Advisors made the stock purchases in the 3rd quarter of 2026.

The players

First Trust Advisors LP

An investment management firm that provides a variety of financial products and services, including mutual funds, exchange-traded funds, and other investment vehicles.

ResMed Inc.

A global medical device company that develops, manufactures, and distributes products for the diagnosis, treatment, and management of respiratory disorders, with a focus on sleep apnea.

Got photos? Submit your photos here. ›

The takeaway

The significant increase in First Trust Advisors' stake in ResMed suggests the investment firm sees strong growth potential in the medical device company, which could signal positive market sentiment around ResMed's business performance and future outlook.